Article
[Immunohistochemical detections of EGFR status in NSCLC].
Zhongguo fei ai za zhi = Chinese journal of lung cancer - 1 Apr 2015
Wang Jie, Liu Chang, Zhong Diansheng, Xu Dongbo, Ning Chao, Ma Qing
Abstract excerpt
BACKGROUND: Patients with non-small cell lung cancer (NSCLC) harboring mutations of the epidermal growth factor receptor (EGFR) respond well to EGFR-tyrosine kinase inhibitor therapy. Immunohistochemistry (IHC) is a simple and widely used technique in clinical pathology laboratories. IHC also features cost effectiveness and rapid detection of EGFR mutations compared with molecular methods. This study aims to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
